Moody Lynn & Lieberson’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $463K | Sell |
|
|||||
|
2025
Q1 | $20.8M | Buy |
|
|||||
|
2024
Q4 | $8.93M | Buy |
|
|||||
|
2024
Q3 | $1.19M | Buy |
|
|||||
|
2024
Q2 | $346K | Sell |
|
|||||
|
2024
Q1 | $2.74M | Sell |
|
|||||
|
2023
Q4 | $12.7M | Sell |
|
|||||
|
2023
Q3 | $18.1M | Sell |
|
|||||
|
2023
Q2 | $20.3M | Buy |
|
|||||
|
2023
Q1 | $21.7M | Sell |
|
|||||
|
2022
Q4 | $23M | Sell |
|
|||||
|
2022
Q3 | $22.8M | Sell |
|
|||||
|
2022
Q2 | $27.9M | Sell |
|
|||||
|
2022
Q1 | $29.7M | Buy |
|
|||||
|
2021
Q4 | $23.3M | Buy |
|
|||||
|
2021
Q3 | $19.8M | Sell |
|
|||||
|
2021
Q2 | $22.6M | Buy |
|
|||||
|
2021
Q1 | $19.6M | Sell |
|
|||||
|
2020
Q4 | $20.1M | Buy |
|
|||||
|
2020
Q3 | $19.3M | Sell |
|
|||||
|
2020
Q2 | $19.2M | Buy |
|
|||||
|
2020
Q1 | $15.7K | Sell |
|
|||||
|
2019
Q4 | $21.7M | Buy |
|
|||||
|
2019
Q3 | $9.56M | Sell |
|
|||||
|
2019
Q2 | $11.7M | Sell |
|
|||||
|
2019
Q1 | $13.1M | Buy |
|
|||||
|
2018
Q4 | $13M | Buy |
|
|||||
|
2018
Q3 | $1.1M | Buy |
|
|||||
|
2018
Q2 | $982K | Sell |
|
|||||
|
2018
Q1 | $1.16M | Buy |
|
|||||
|
2017
Q4 | $1.08M | Sell |
|
|||||
|
2017
Q3 | $1.08M | Sell |
|
|||||
|
2017
Q2 | $948K | Sell |
|
|||||
|
2017
Q1 | $975K | Sell |
|
|||||
|
2016
Q4 | $1.06M | Sell |
|
|||||
|
2016
Q3 | $980K | Sell |
|
|||||
|
2016
Q2 | $1.95M | Buy |
|
|||||
|
2016
Q1 | $1.69M | Sell |
|
|||||
|
2015
Q4 | $5.65M | Buy |
|
|||||
|
2015
Q3 | $1.9M | Sell |
|
|||||
|
2015
Q2 | $2.31M | Sell |
|
|||||
|
2015
Q1 | $2.25M | Sell |
|
|||||
|
2014
Q4 | $2.17M | Buy |
|
|||||
|
2014
Q3 | $1.81M | Sell |
|
|||||
|
2014
Q2 | $1.74M | Sell |
|
|||||
|
2014
Q1 | $2.14M | Buy |
|
|||||
|
2013
Q4 | $1.99M | Sell |
|
|||||
|
2013
Q3 | $1.76M | Sell |
|
|||||
|
2013
Q2 | $1.75M | Buy |
|